Clinical Trials Directory

Trials / Completed

CompletedNCT03557450

A Feasibility Study to Determine PET/CT Imaging of Blood Flow to the Bone

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
3 (actual)
Sponsor
University of California, Davis · Academic / Other
Sex
All
Age
20 Years – 75 Years
Healthy volunteers
Accepted

Summary

To evaluate if a commonly used medical bone scan, called positron emission tomography/computed tomography (PET/CT) with sodium fluoride can measure bone blood flow to the hip.

Detailed description

The purpose of this research is to validate technique on a commonly used medical bone scan, called positron emission tomography/computed tomography (PET/CT) along with sodium fluoride as the tracer for determining blood flow to the bone. Up to 12 subjects will have PET/CT scans so that we can determine the repeatability and reliability of the images prior to using PET/CT for this use on subjects in the Phase 1b part of Dr. Nancy Lane's clinical research study entitled "A Phase 1, Randomized, Double-Blind, Placebo-Controlled Single and Multiple Ascending Dose Study of the Safety and Tolerability of Intravenous LLP2A-Alendronate in Adult Men and Women with Osteopenia Secondary to Glucocorticoids" (IRB Protocol #866350).

Conditions

Interventions

TypeNameDescription
DEVICEPET/CT ScanPET/CT scanning with sodium fluoride

Timeline

Start date
2018-06-11
Primary completion
2019-03-25
Completion
2019-03-25
First posted
2018-06-15
Last updated
2019-05-30

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03557450. Inclusion in this directory is not an endorsement.